CoinVoice has recently learned that on October 9, the longevity research community VitaDAO announced the establishment of a biotechnology company, Matrix Biosciences. The company initially raised $300,000 in financing, and more funds will be in place in early 2024.

It was also reported that the company will expand its research on the longevity and cancer resistance of naked mole-rat and study whether compounds found in naked mole-rat can extend human lifespan.

CoinVoice previously reported that on January 30, the decentralized scientific research community VitaDAO completed a $4.1 million financing round. This round of financing was participated by Pfizer Ventures, Shine Capital, L1 Digital, Beaker DAO and Spaceship DAO, etc. Angel investors include Coinbase's former chief technology officer and a16z general partner Balaji Srinivasan. The funds from this round of financing will be used to further promote longevity research projects. [Original link]